Raymond James & Associates’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $368K | Sell |
80,706
-5,353
|
|
||||
|
2024
Q2 | $374K | Buy |
86,059
+1,010
|
|
||||
|
2024
Q1 | $427K | Sell |
85,049
-2,000
|
|
||||
|
2023
Q4 | $546K | Buy |
87,049
+5,377
|
|
||||
|
2023
Q3 | $582K | Buy |
81,672
+4,420
|
|
||||
|
2023
Q2 | $787K | Buy |
77,252
+7,401
|
|
||||
|
2023
Q1 | $634K | Buy |
69,851
+18,093
|
|
||||
|
2022
Q4 | $371K | Buy |
+51,758
|
|